Moderator: Mingliang Zhang PhD, Senior Director, Worldwide Market Access, Global Strategic Marketing and Market Access, Johnson and Johnson Pharmaceutical Services, Raritan, NJ, USA
Panelists: Nara Decharin PhD, Manager, AstraZeneca Thailand, Bangkok, Thailand; Yen-Huei (Tony) Tarn PhD, MS, Executive Director, Center for Pharmaceutical Care Development, National Union of Pharmacist Association, Taipei, Taiwan; Su-Kyoung Ko PhD, Director, Head of Market Access, Market Access Division, Pfizer Korea, Seoul, South Korea

Moderator: Lisbet Coulton, Director, International Pricing and Reimbursement, United BioSource Corporation - Europe, London, UK
Panelists: Abdulkadir Keskinaslan MD, MBA, MPH, Market Pricing Director Asia, Novartis Pharma AG, Basel, Switzerland; Nathorn Chaiyakunapruk PharmD, PhD, Associate Professor, Center of Pharmaceutical Outcome Research, Department of Pharmacy Practice, Naresuan University, Muang, Phitsanulok, Thailand; Wen Chen PhD, Professor, Center for Pharmacoeconomic Research and Evaluation, Fudan University, Shanghai, China

Discussion Leaders: David Thompson PhD, Senior Vice President, Health Economics & Strategic Consulting, i3 Innovus, Medford, MA, USA; George Papadopoulos BSc, President, Emerald CG, McMahon's Point, NSW, Australia

Discussion Leaders: Isao Kamae MD, DrPH, Professor of Pharmacoeconomics, JPMA Research and Education Project, Graduate School of Health Management, Keio University, Fujisawa-City, Kanagawa, Japan; Makoto Kobayashi ME, Director, CRECON Research & Consulting Inc, Tokyo, Japan; Naohiro Nakahara BSc, Research Scientist, Health Outcomes Research, Medical Science, Eli Lilly Japan K.K., Kobe, Japan

Discussion Leaders: Jeff J. Guo PhD, RPh, Associate Professor of Pharmacoeconomics & Pharmacoepidemiology, University of Cincinnati Medical Center, Cincinnati, OH, USA; Shu Chuen Li PhD, MBA, MSc, BSc, Professor, Chair & Head, University of Newcastle, School of Biomedical Sciences, Callaghan, NSW, Australia; Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, and Director, Center for Health Development Research, Shanghai Bureau of Health, Shanghai, China; Kenneth KC Lee PhD, Professor, School of Pharmacy, The Chinese University of Hong Kong, Hong Kong, China

Moderator: Yot Teerawattananon MD, PhD, Program Leader, Health Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand
Panelists: Scott Ramsey PhD, MD, Full Member & Professor, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA; Laura Sampietro-Colom MD, PhD, President, Health Technology Assessment International (HTAi), Edmonton, AB, Canada; Kalipso Chalkidou PhD, MD, Director - NICE International, National Institute for Health and Clinical Excellence, London, UK (Speakers at this panel are invited)

Discussion Leaders: Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan; Lillian YJ Wang MA, Senior Market Access Manager, Novartis (Taiwan) Co., Ltd., Taipei, Taiwan; Jittrakul Leartsakulpanitch PhD, Outcomes Research Associate, Pfizer (Thailand) Limited, Bangkok, Thailand

Discussion Leaders: J. Jaime Caro MD, Senior Vice President of Health Economics, United BioSource Corporation, Lexington, MA, USA; Charalabos-Markos Dintsios MPH, MA, Scientific Staff Department of Health Economics, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; Anja Schwalm MSc, Health Economist, Health Economics, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany; Isao Kamae MD, DrPH, Professor of Pharmacoeconomics, JPMA Research and Education Project, Graduate School of Health Management, Keio University, Fujisawa-City, Kanagawa, Japan

Discussion Leaders: Sarah Norris BSc, MPhil, PhD, Director, Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; Ray Kirk PhD, MSc, BSc, Associate Professor, Health Sciences Centre, Christchurch, New Zealand; Paul Scuffham PhD, Professor of Health Economics, Griffith University, Meadowbrook, Australia

Moderators: Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, and Director, Center for Health Development Research, Shanghai Bureau of Health, Shanghai, China; Syed Mohamed Aljunid MD, MSc, PhD, FAMM

Professor of Health Economics and Senior Research Fellow, United Nations University-International Institute of Global Health (UNU-IIGH), National University of Malaysia, Kuala Lumpur, Malaysia

Panelists: Vithaya Kulsomboon PhD, Associate Dean/Associate Professor, Department of Social and Administrative Pharmacy, Chulalongkorn University, Patumwan, Payathai, Bangkok, Thailand; Hsiang-Wen Lin PhD, Assistant Professor, School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan; Mohammadreza Amiresmaili PhD, Assistant Professor, Health Management, Kerman Medical University, Kerman, Iran; Sirada Maphanta PharmD, MS, Director, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Muang, Phitsanulok, Thailand

Moderator: William Montgomery RPh, Senior Research Scientist, Eli Lilly and Company, West Ryde, NSW, Australia
Panelists: Rosalie Viney PhD, Associate Professsor, Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Broadway, NSW, Australia; Michael Drummond PhD, Professor of Health Economics, Centre for Health Economics, University of York, York, UK; Ruth Lopert BSc, BMed, BMedSci, Principal Medical Adviser, Therapeutic Goods Administration, Canberra, Australia

Moderator: Diana Brixner RPh, PhD, Professor and Chair, Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA
Panelists: Gordon G. Liu PhD, Professor of Economics, Executive Director, The Health Economics and Management Institute, Guanghua School of Management, Peking University, Beijing, China; Abdulkadir Keskinaslan MD, MBA, MPH, Market Pricing Director Asia, Novartis Pharma AG, Basel, Switzerland; Alan Haycox BA, MA, PhD, Reader in Health Economics, University of Liverpool, Liverpool, UK

Discussion Leaders: Eric Q Wu PhD, Vice President, Analysis Group, Inc., Boston, MA, USA; Dezhi Yu PhD, Director, China Ministry of Health, Beijing, Beijing, China; Jipan Xie MD, PhD, Associate, Analysis Group, Inc., Boston, MA, USA; Ruimin Gu PhD, College of Pharmacy, Nankai University, Tianjin, China

Discussion Leaders: Supasit Pannarunothai MD, PhD, Professor, Community Family and Occupational Medicine, Naresuan University, Muang, Phitsanulok, Thailand; Boonchai Kijsanayotin MD, PhD, Director, Bureau of Policy and Strategy, Ministry of Public Health, Muang, Nonthaburi, Thailand; Nilawan Upakdee PhD, Director, Naresuan University, Muang, Phitsanulok, Thailand; Orathai Khiaocharoen MEd, Phitsanulok Provincial Health Office, Muang, Phitsanulok, Thailand

Discussion Leaders: Wen Chen PhD, Professor, Center for Pharmacoeconomic Research and Evaluation, Fudan University, Shanghai, China; Chao-Hsiun Tang PhD, Professor, School of Health Care Administration, Taipei Medical University, Taipei, Taiwan; Bruce Crawford MA, MPH, General Manager, Asia, Mapi Values, Tokyo, Japan; Jennifer Sung MS, PharmD, Executive Director, Health Economics & Outcomes Research, Global Health Economics & Outcomes Research, Novartis Pharmaceuticals Corporation, Shanghai, China

Moderator: Vithaya Kulsomboon PhD, Associate Dean/Associate Professor, Department of Social and Administrative Pharmacy, Chulalongkorn University, Bangkok, Thailand
Panelists: Sang-Eun Choi MPh, PhD, Professor, College of Pharmacy, Seoul National University, Seoul, South Korea; Gary Oderda PharmD, MPH, Professor, Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA; Netnapis Suchonwanich MS, Pharm, Assistant Secretary General, National Health Security Office, Bangkok, Thailand

Moderator: Adele Weston PhD, Director, Health Technology Analysts Pty Ltd, Balmain NSW, Australia
Panelists: Paul Scuffham PhD, Professor of Health Economics, Griffith University, Meadowbrook, Australia; Rosalie Viney PhD, Associate Professor, Centre for Health Economics Research and Evaluation, University of Technology, Sydney, Broadway, NSW, Australia; Cammy Yuen, Director Market Access, Abbott Australia, Sydney, Australia

Discussion Leaders: Alex Z. Fu PhD, Assistant Professor, Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA; Nan Luo PhD, Assistant Professor, Department of Epidemiology and Public Health & Centre for Health Services Research, National University of Singapore, Singapore

Discussion Leaders: Eui-Kyung Lee PhD, ISPOR Korea Chapter President & Professor, Graduate School of Clinical Pharmacy, Sookmyung Women’s University, Seoul, South Korea; Jeonghoon Ahn PhD, MA, ISPOR Korea Chapter Secretary and Senior Director, National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea; Sukyoung Ko PhD Korea Chapter member and Director, Department of Market Access, Pfizer Korea, Seoul, South Korea